Echo-doppler monitoring of asymptomatic distal deep vein thrombosis in patients given low-molecular-weight-heparin at prophylactic doses after orthopedic surgery
Barrellier, M.T.; Le Hello, C.; Verfaille, M.; Vignon, C.; Bertin, T.; Boissel, M.; Dubois, F.; Fauchon, G.; Pegoix, M.; Thomassin, C.; Trahay, A.; Aubriot, J.H.; Vielpeau, C.
Journal des Maladies Vasculaires 25(3): 195-200
2000
ISSN/ISBN: 0398-0499 PMID: 10913931 Document Number: 518840
Document emailed within 1 workday
Related Documents
Akanmu, A.S.; Nnodu, O.E.; Giwa, S.O.; Salako, L.A.; Akinsete, I.; Adebule, G.T.; Adekoya-Cole, T.O.; Odunubi, O.O. 2004: Efficacy and safety of enoxaparin, a low molecular weight heparin in the prevention of deep vein thrombosis in Nigerian patients after orthopaedic surgery African Journal of Medicine and Medical Sciences 33(4): 335-340Haas, S.; Stemberger, A.; Fritsche, H.M.; Welzel, D.; Wolf, H.; Lechner, F.; Blümel, G. 1987: Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine Arzneimittel-Forschung 37(7): 839-843
Hull, R.D.; Pineo, G.F.; Stein, P.D.; Mah, A.F.; MacIsaac, S.M.; Dahl, O.E.; Ghali, W.A.; Butcher, M.S.; Brant, R.F.; Bergqvist, D.; Hamulyák, K.; Francis, C.W.; Marder, V.J.; Raskob, G.E. 2001: Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review Archives of Internal Medicine 161(16): 1952-1960
Zidane, M.; van Hulsteijn, L.H.; Brenninkmeijer, B.J.; Huisman, M.V. 2006: Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice Haematologica 91(8): 1052-1058
Forbes, C.D. 1989: Prevention of deep vein thrombosis--use of the low molecular weight heparin enoxaparin British Journal of Clinical Practice 43(11): 396-400
Alonso Martínez, J.L.; Abínzano Guillén, M.L.; Urbieta Echezarreta, M.A.; Annichérico Sánchez, F.J.; Fernández Ladrón, V.; García Sanchotena, J.L. 2008: Low-molecular-weight heparin without oral anticoagulants for the treatment of deep vein thrombosis Anales de Medicina Interna 25(1): 4-8
Levine, M.N.; Planes, A.; Hirsh, J.; Goodyear, M.; Vochelle, N.; Gent, M. 1989: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement Thrombosis and Haemostasis 62(3): 940-944
Strand, L.; Bank-Mikkelsen, O.K.; Lindewald, H. 1975: Small heparin doses as prophylaxis against deep-vein thrombosis in major surgery Acta Chirurgica Scandinavica 141(7): 624-627
Yang, Z.; Liu, X.; Dai, S.; Liu, K.; Zhang, Y.; Sun, J.; Yin, X. 2010: Effectiveness of low molecular weight heparin for prevention of deep vein thrombosis after total hip arthroplasty Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 24(9): 1058-1061
Savage, K.J.; Wells, P.S.; Schulz, V.; Goudie, D.; Morrow, B.; Cruickshank, M.; Kovacs, M.J. 1999: Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity Thrombosis and Haemostasis 82(3): 1008-1010
Labas, P.; Ohrádka, B.; Vladimír, J.; Cambal, M. 2000: The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression International Angiology: a Journal of the International Union of Angiology 19(4): 303-307
Schwarz, B.; Mittelmeier, H. 1988: Initial clinical experiences with low molecular weight heparin in the prevention of thrombosis in orthopedic surgery Aktuelle Traumatologie 18(5): 226-232
Kakkar, V.V.; Corrigan, T.; Spindler, J.; Fossard, D.P.; Flute, P.T.; Crellin, R.Q.; Wessler, S.; Yin, E.T. 1972: Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial Lancet 2(7768): 101-106
Boccalon, H.; Elias, A.; Chalé, J.J.; Cadène, A.; Gabriel, S. 2000: Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study Archives of Internal Medicine 160(12): 1769-1773
Wei, N.; Qi, Y.; Yang, H.; Guo, L. 2018: Clinical observation of the efficacy of low-molecular-weight heparin calcium in prophylaxis of the deep venous thrombosis following the gynecological tumor surgery Pakistan Journal of Pharmaceutical Sciences 31(6(Special): 2835-2839
Kettunen, K.; Poikolainen, E.; Karjalainen, P.; Oksala, I.; Alhava, E.; Rehnberg, V.; Huttunen, H.; Mattila, M. 1974: Prevention of postoperative deep vein thrombosis with small doses of heparin Duodecim; Laaketieteellinen Aikakauskirja 90(11): 834-838
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Fluh, D. 1990: Clinical monitoring and prevention of deep vein thrombosis in an orthopedic department: use of enoxaparin for a year Agressologie: Revue Internationale de Physio-Biologie et de Pharmacologie Appliquees Aux Effets de l'Agression 31(3): 151-153
Nesvold, A.; Ly, B.; Abildgaard, U.; Stiris, M. 1991: Treatment of deep venous thrombosis with low molecular weight heparin (Fragmin) Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 111(27): 3296-3297
Volteas, S.K.; Kalodiki, E.; Nicolaides, A.N. 1996: Low molecular weight heparins in the initial treatment of deep vein thrombosis International Angiology: a Journal of the International Union of Angiology 15(1): 67-74